Immunotherapy: Magic Bullet to Change the Future Therapeutics
- 1st Edition, Volume 144 - February 24, 2025
- Latest edition
- Editors: Vijay Kumar Prajapati, Rossen Donev
- Language: English
FORMTEXT Immunotherapy is emerging as a novel and reliable therapeutic technique for treating diseases such as autoimmunity, HIV/AIDS, allergy and cancers. Immunotherapy change or… Read more
- Immunotherapy
- Monoclonal antibody
- Cytokines
Vijay Kumar Prapajati
2. Development of Pancreatic cancer immunotherapy
Vijay Kumar Prapajati
3. Exploring immunotherapy with Antibody-drug conjugates in solid tumor oncology
Vijay Kumar Prapajati
4. Exploring development of check-point inhibitors to develop human immunotherapy
Vijay Kumar Prapajati
5. Immunotherapy in the Management of Inflammatory Bone Loss in Osteoporosis
Rupesh K. Srivastava
6. Immunotherapy to CD5, a T cell antigen having roles from development to peripheral function: future prospective and challenges
Ambak K. Rai
7. Nanobody based cancer immunotherapy: prospects and challenges
Sanjana Mehrotra
8. Monoclonal antibodies- a repertoire of therapeutics
Suman Tapryal
9. Navigating the Landscape: A Comprehensive Overview of Computational Approaches in Developing Therapeutic Antibodies
Aditya K. Padhi
10. Host Directed Immunotherapy in chronic diseases: From cancer to parasitic infections
Rajiv Kumar
- Edition: 1
- Latest edition
- Volume: 144
- Published: February 24, 2025
- Language: English
VP
Vijay Kumar Prajapati
Dr. Vijay Kumar Prajapati is an Associate Professor in the Department of Biochemistry at the University of Delhi South Campus, New Delhi, India. He specializes in cell-death research, parasitology, and therapeutic developments for infectious diseases. He has published extensively in international journals and contributed chapters to reputable publishers. He is a recipient of the INSA Medal for Young Scientist from the Indian National Science Academy and an Associate of the Indian Academy of Sciences, Bengaluru. His work has appeared in leading journals spanning infectious diseases and cellular physiology, reflecting a high scholarly impact and a broad research portfolio.
RD